Navigation Links
Children's Hospital Boston, eClinicalWorks Team to Push Clinical Information Into Patients' Personally Controlled Health Records
Date:9/14/2009

/i>With an established customer base of more than 30,000 providers and 100,000 healthcare professionals across all 50 states, eClinicalWorks has been awarded multiple top industry honors including being named to the Inc. 500 in 2008 and 2007, and prominently placed in a report released by IDC company Health Industry Insights, titled Healthcare Provider Industry Short List: Ambulatory Electronic Health Records and Electronic Medical Records. Based in Westborough, Mass., eClinicalWorks has additional offices in New York City and Alpharetta, Ga. More information on eClinicalWorks can be found at www.eclinicalworks.com or by calling 866-888-MYCW.

    CONTACT:
    Keri Stedman                         Heather Caouette
    Children's Hospital Boston           eClinicalWorks
    617-919-3114                         508-836-2700
    keri.stedman@childrens.harvard.edu   Heather.c@eclinicalworks.com


'/>"/>
SOURCE Children's Hospital Boston
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Childrens Hospital Los Angeles Completes Conversion to Masimo SET(R) Pulse Oximetry Technology
2. 200 Families of Children With Serious Eye Problems Benefit From Unique Gift Card Program at The Vision Center at Childrens Hospital Los Angeles
3. Childrens Bedding Naturally Enhances Emotional Well-being
4. Cydcor Builds Bears and Bonds in Special Charity Event Benefitting Childrens Hospital Los Angeles
5. National Childrens Study Begins Recruiting
6. Jessica Biel and Make The Difference Network Bring Holiday Cheer to Childrens Hospital Los Angeles
7. Siegel+Gale Designs New HOPE Portal for Childrens Hospital Los Angeles
8. Childrens Hospital Los Angeles Turns Off the Tap With Green Earth Waterless Carwash
9. Nautica Malibu Triathlon Presented by Toyota Raises $718,000 for Childrens Hospital Los Angeles Pediatric Cancer Research
10. Bangkok Hospital Group and IBM Collaborate on Smarter Healthcare Initiative
11. Report Cards for Hospitals May Be Misleading
Post Your Comments:
*Name:
*Comment:
*Email:
Other Medicine News:Health News:CVS Joins Retail Push for Non-Toxic Personal Care Products 2Health News:CVS Joins Retail Push for Non-Toxic Personal Care Products 3Health News:The Female Health Company Schedules Second Quarter Conference Call for May 14, 2008 2Health News:AIDS.gov Goes 2.0: Government HIV/AIDS Website Now Features a Blog, Podcasts, and More 2Health News:Hunger Hormone Makes Food Look More Tasty 2Health News:Hunger Hormone Makes Food Look More Tasty 3Health News:Kendle Delivers Record Net Service Revenues and New Business Authorizations for First Quarter 2008 2Health News:Kendle Delivers Record Net Service Revenues and New Business Authorizations for First Quarter 2008 3Health News:Kendle Delivers Record Net Service Revenues and New Business Authorizations for First Quarter 2008 4Health News:Kendle Delivers Record Net Service Revenues and New Business Authorizations for First Quarter 2008 5Health News:Kendle Delivers Record Net Service Revenues and New Business Authorizations for First Quarter 2008 6Health News:Kendle Delivers Record Net Service Revenues and New Business Authorizations for First Quarter 2008 7Health News:Weill Cornell Medical College Announces First Commencement of Its New Medical School Graduates in Doha, Qatar, May 8, 2008 2Health News:Weill Cornell Medical College Announces First Commencement of Its New Medical School Graduates in Doha, Qatar, May 8, 2008 3Health News:Weill Cornell Medical College Announces First Commencement of Its New Medical School Graduates in Doha, Qatar, May 8, 2008 4Health News:Weill Cornell Medical College Announces First Commencement of Its New Medical School Graduates in Doha, Qatar, May 8, 2008 5
Breaking Medicine Technology:AdEx Media, Inc. Signs Agreement with Medical Alarm Concepts 2AdEx Media, Inc. Signs Agreement with Medical Alarm Concepts 3Negative Pressure Wound Devices Draw FDA Notice, Advice 2FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 2FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 3FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 4Photo 3A Poor Disabled Children in Ecuador Receive Free Wheelchairs 21 56135 1Photo 3A Poor Disabled Children in Ecuador Receive Free Wheelchairs 21 56135 2Photo 3A Poor Disabled Children in Ecuador Receive Free Wheelchairs 21 56135 3Dominion Diagnostics to Host Open House Reception in New Vermont Laboratory Facility 56131 1Dominion Diagnostics to Host Open House Reception in New Vermont Laboratory Facility 56131 2Regado Biosciences to Present at the Rodman 26 Renshaw Global Investment Conference on September 10 2009 13829 1Regado Biosciences to Present at the Rodman 26 Renshaw Global Investment Conference on September 10 2009 13829 2
Other Medicine Technology:Data Presented at AACR Meeting Shows Bavituximab Equivalent Plus,Docetaxel Reduces Growth of Both Hormone-Dependent and,Hormone-Independent Prostate Cancer by Up to 94 Percent in,Preclinical Studies 2Data Presented at AACR Meeting Shows Bavituximab Equivalent Plus,Docetaxel Reduces Growth of Both Hormone-Dependent and,Hormone-Independent Prostate Cancer by Up to 94 Percent in,Preclinical Studies 3Data Presented at AACR Meeting Shows Bavituximab Equivalent Plus,Docetaxel Reduces Growth of Both Hormone-Dependent and,Hormone-Independent Prostate Cancer by Up to 94 Percent in,Preclinical Studies 4Data Presented at AACR Meeting Shows Bavituximab Equivalent Plus,Docetaxel Reduces Growth of Both Hormone-Dependent and,Hormone-Independent Prostate Cancer by Up to 94 Percent in,Preclinical Studies 5OncoGenex Technologies Announces Phase II Data of OGX-011 in,Metastatic Breast Cancer at American Association for Cancer,Research 2007 Annual Meeting 2OncoGenex Technologies Announces Phase II Data of OGX-011 in,Metastatic Breast Cancer at American Association for Cancer,Research 2007 Annual Meeting 3OncoGenex Technologies Announces Phase II Data of OGX-011 in,Metastatic Breast Cancer at American Association for Cancer,Research 2007 Annual Meeting 4